This is the year you finally find a liquid lipstick that lasts, stop letting dishes pile up in the sink, and upgrade your WFH ...
Meanwhile, Cocrystal Pharma has announced its intent to extend enrolment for its Phase IIa human challenge trial of the oral influenza polymerase basic 2 (PB2) inhibitor, CC-4234. Give your business ...
Credit: Yurii_Yarema / Shutterstock. Cocrystal Pharma has announced its intent to extend enrolment for its Phase IIa human challenge trial of the oral influenza polymerase basic 2 (PB2) inhibitor, ...
Ph.D. Program in Nanoscience and Nanotechnology (International Program/Interdisciplinary), Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand Center of Excellence in Materials ...